# Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer

Source: https://onco.cc/trials/nct07372300/  
OnCo record `nct07372300` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Shih-Kai Hung, now recruiting.

## Summary

Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer is a phase 3, randomised interventional study registered as NCT07372300 by Shih-Kai Hung, with a registry enrolment figure of 126 participants, started 2025-09-23 and due to reach its primary completion in 2027-12-31. Interventions recorded: Hyperthermia. Conditions listed: Locally Advanced Rectal Carcinoma. Primary outcome: Down-staging Rate. Colorectal eligibility wording from the registry: "Initial pathological diagnosis of adenocarcinoma of the rectum". Sites: Taiwan. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: mEHT
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07372300
- Phase: 3
- Setting: The Efficacy of Combination of Modulated Electro-Hyperthermia(mEHT) in The Multimodality Management in Locally Advanced Rectal Cancer: A Multicenter Phase 3 Randomized Control Trial.
- Sponsor: Shih-Kai Hung
- Enrolled: 126

## Sources

- ClinicalTrials.gov NCT07372300: https://clinicaltrials.gov/study/NCT07372300

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07372300.json